Watch the Event
The legal sale of recreational marijuana remains limited to a handful of states, but 29 states plus the District of Columbia allow the prescription and distribution of medical marijuana. Ten of those states—which represent 115 electoral votes—went for President Trump in the 2016 election. National polling shows that just over half of Americans favor marijuana legalization, but a much larger majority want the federal government to leave marijuana alone in states where it is legal.
While candidate Trump promised to protect medical marijuana on the campaign trail, President Trump’s Justice Department wants to be more aggressive against state‐legal marijuana under the Controlled Substances Act (CSA). Ultimately, Congress holds the reins on the Department of Justice’s ability to enforce particular provisions of the CSA and determines which substances should be under federal control.
While marijuana decriminalization is often thought to be a Democrat‐friendly topic, some of the best arguments for federal recognition of state marijuana policy rest in traditional Republican values of federalism, deference to local policy choices, and a limited federal government. Moreover, businesses that have no direct ties to cannabis cultivation or distribution like banks and financial institutions can benefit from clear federal rules that tolerate state‐legal marijuana transactions.
Join us for a lunchtime discussion to explore several ways Congress can reshape federal marijuana policy in a manner that is more consistent both with public opinion and the conservative values of limited government, federalism, and local policymaking.